LLAClass II
Direct Agglutination Test, Toxoplasma Gondii
21 CFR 866.3780 / Microbiology
LLA is the FDA product code for Direct Agglutination Test, Toxoplasma Gondii, a class II device type, regulated under 21 CFR 866.3780. As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- LLA
- Device name
- Direct Agglutination Test, Toxoplasma Gondii
- Regulation
- 21 CFR 866.3780
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 4
- Ingested recalls
- 0
Clearances, product code LLA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1983 | 1 |
| 1985 | 1 |
| 1989 | 1 |
| 1993 | 1 |
Applicants with the most clearances
Product code LLA| Applicant | Clearances |
|---|---|
| BD Becton Dickinson Vacutainer Systems Preanalytic | 2 |
| Ampcor, Inc. | 1 |
| Biokit USA, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
